nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advanced In Vitro HepaRG Culture Systems for Xenobiotic Metabolism and Toxicity Characterization
|
Ashraf, Muhammad Nadeem |
|
2018 |
44 |
4 |
p. 437-458 |
artikel |
2 |
A Gallbladder-Based Enterohepatic Circulation Model for Pharmacokinetic Studies
|
Okour, Malek |
|
2018 |
44 |
4 |
p. 493-504 |
artikel |
3 |
Clinical Pharmacokinetics of a Lipid-Based Formulation of Risperidone, VAL401: Analysis of a Single Dose in an Open-Label Trial of Late-Stage Cancer Patients
|
Dilly, Suzanne J. |
|
2019 |
44 |
4 |
p. 557-565 |
artikel |
4 |
Comparison of the Pharmacokinetic Profiles of Ceftriaxone Used Alone and Combined with Danhong Injection in Old Rats
|
Zhang, Qian |
|
2018 |
44 |
4 |
p. 505-517 |
artikel |
5 |
Conversion from Twice-Daily Prograf® to Once-Daily Advagraf® in Multi-ethnic Asian Adult Renal Transplant Recipients With or Without Concomitant Use of Diltiazem: Impact of CYP3A5 and MDR1 Genetic Polymorphisms on Tacrolimus Exposure
|
Yau, Wai-Ping |
|
2018 |
44 |
4 |
p. 481-492 |
artikel |
6 |
Effect of Gender on the Pharmacokinetics of ON 123300, A Dual Inhibitor of ARK5 and CDK4/6 for the Treatment of Cancer, in Rats
|
Mudunuru, Jennypher |
|
2019 |
44 |
4 |
p. 531-538 |
artikel |
7 |
Enhancing Curcumin Oral Bioavailability Through Nanoformulations
|
Ipar, Vinod S. |
|
2019 |
44 |
4 |
p. 459-480 |
artikel |
8 |
Glucuronidation of d-Luciferin In Vitro: Isoform Selectivity and Kinetics Characterization
|
Xia, Yangliu |
|
2019 |
44 |
4 |
p. 549-556 |
artikel |
9 |
Influence of Obesity and Type 2 Diabetes Mellitus on the Pharmacokinetics of Tramadol After Single Oral Dose Administration
|
Porażka, Joanna |
|
2019 |
44 |
4 |
p. 579-584 |
artikel |
10 |
In-Vivo Degradation of DNA-Based Therapeutic BC 007 in Humans
|
Davideit, Hanna |
|
2019 |
44 |
4 |
p. 567-578 |
artikel |
11 |
Population Pharmacokinetic Modelling of Pyrazinamide and Pyrazinoic Acid in Patients with Multi-Drug Resistant Tuberculosis
|
Mugabo, Pierre |
|
2019 |
44 |
4 |
p. 519-530 |
artikel |
12 |
Tacrolimus Variability: A Cause of Donor-Specific Anti-HLA Antibody Formation in Children
|
Kaya Aksoy, Gulsah |
|
2019 |
44 |
4 |
p. 539-548 |
artikel |